|View printer-friendly version|
Array BioPharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
BOULDER, Colo.--(BUSINESS WIRE)--Oct. 31, 2007--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 5 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at large market opportunities. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
CONTACT: Array BioPharma Inc.